Back to search
FDAFDA · Food and drugs·Recall number D-1289-2020

Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478.

Published June 10, 2020 · Recall initiated: May 28, 2020

Summary

FDA records drug Class III recall D-1289-2020, published June 10, 2020 and initiated May 28, 2020. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 4124 bottles; Lot: Lot #: a) 25634, b) 25633; Exp. 09/30/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance consistent with granules from desiccant packs used during storage

What to do

Voluntary: Firm initiated · Letter

Get an email if LAMOTRIGINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LAMOTRIGINE
Manufacturer
AVKARE Inc.
Distributor
Nationwide in the U.S.
UPC
0342291368606
Lot
Lot #: a) 25634, b) 25633; Exp. 09/30/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478. recalled?

Yes. FDA published recall D-1289-2020 on June 10, 2020. Reported hazard: Presence of Foreign Substance consistent with granules from desiccant packs used during storage

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LAMOTRIGINE. UPC: 0342291368606.